#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Becker's muscular dystrophy Acute graft versus host disease in liver Follicular lymphoma stage II Neuromyelitis optica spectrum disorder Richter's syndrome Chondrodystrophy Thromboangiitis obliterans Diffuse large B-cell lymphoma refractory Mantle cell lymphoma stage III Systemic lupus erythematosus Myelodysplastic syndrome Prostate cancer Ventricular fibrillation B-cell small lymphocytic lymphoma Infertility female More trials…
Learn about Rare Diseases

Acute respiratory distress syndrome – Trials in Disease Basal cell naevus syndrome – Basic Information Pemphigoid Friedreich’s ataxia – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Ehlers-Danlos syndrome – Treatment Marginal zone lymphoma – Trials in Disease Basal cell naevus syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Hereditary motor and sensory neuropathy – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Iodixanol Dabigatran Phenol Dipyridamole Gen1046 Ulipristal Acetate Myrrh Peginterferon Alfa-2A Magnesium Procarbazine 534 Dermatophagoides Farinae VERTEPORFIN Bromocriptine Ceftriaxone Tumour Detection Etoricoxib BIIB115 Nilotinib Mepolizumab More therapies…

Learn about Your Condition

Vulvovaginal candidiasis Herpes zoster Hyperadrenocorticism Erdheim-Chester disease Staphylococcal infection Thrombosis prophylaxis Pulmonary sarcoidosis Breast cancer recurrent Cluster headache Pulmonary venous thrombosis Psoriatic arthropathy Ebola disease Liver disorder Wheezing Tooth loss More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Gaucher’s disease type III

Study on the Effectiveness and Safety of Venglustat for Adults and Children with Gaucher Disease Type 3

Not recruiting

3 1 1
Investigated Diseases:
- Gaucher’s disease type III
Investigated Drugs:
- Imiglucerase
- Venglustat
Study of Eliglustat alone or with Imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3

Not recruiting

3 1 1 1
Investigated Diseases:
- Gaucher’s disease type I
- Gaucher’s disease type III
Investigated Drugs:
- Eliglustat Tartrate
- Imiglucerase
Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

Not recruiting

2 1 1 1
Investigated Diseases:
- Gaucher’s disease type I
- Gaucher’s disease type III
Investigated Drugs:
- Imiglucerase
- Venglustat

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Gaucher’s disease type III

Study on the Effectiveness and Safety of Venglustat for Adults and Children with Gaucher Disease Type 3

Study of Eliglustat alone or with Imiglucerase in children and adolescents aged 2-17 years with Gaucher disease type 1 and type 3

Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies